In response to the COVID-19 situation, OCLI is following enhanced safety protocols consistent with guidelines put forth by the CDC and the World Health Organization (WHO) to protect our patients and colleagues.
Click here to learn about how we are keeping you safe.
I read an interesting article in this week’s Ophthalmology Times.
A recent study by Dr. David Freidman of the Wilmer Eye Institute found that a group of 66 glaucoma patients only took their once a day drop 75% of the time. These patients were than split into 2 groups, a control group and a intervention group.
The control group received a prescription and instructions on use of the drop. The intervention group were also shown a video showing how to take the drop, were counseled on barriers to taking drops and solutions, received reminders via phone, and used an alarm to remind them to take their drop.
The results: an improvement in compliance by 20% in the intervention group and no change in the control group!
A new study is underway by Dr. Michael Boland to determine if compliance can be improved with the use of such technologies as text messaging, phone calls, and drop bottles embedded with microchips.
TAKE HOME MESSAGE: Patient compliance can be improved thru education and reminder systems.
Our world-class team of professionals at OCLI can help you with the latest treatment options for you.
Request an appointment
Are you a new patient? *
Please choose your preferred provider: *
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia and specialize in primary vision care, LASIK, cataract surgery, glaucoma, diabetic eye care, and other services for patients in the Northeast.
